PGE2 in fibrosis and cancer: Insights into fibroblast activation
•Fibroblasts are the main cells of connective tissue and participate in wound repair upon activation.•Unchecked fibroblast activation leads to fibrosis and contributes to cancer development.•PGE2 restricts fibroblast activation in fibrosis, thereby acting in an anti-fibrotic manner.•While PGE2 is co...
Uložené v:
| Vydané v: | Prostaglandins & other lipid mediators Ročník 143; s. 106339 |
|---|---|
| Hlavní autori: | , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Elsevier Inc
01.08.2019
|
| Predmet: | |
| ISSN: | 1098-8823 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | •Fibroblasts are the main cells of connective tissue and participate in wound repair upon activation.•Unchecked fibroblast activation leads to fibrosis and contributes to cancer development.•PGE2 restricts fibroblast activation in fibrosis, thereby acting in an anti-fibrotic manner.•While PGE2 is considered a tumor-promoting lipid, its role in cancer-associated fibroblast activation is unclear.
Fibroblasts are the essential cellular architects of connective tissue and as such are crucial cells in contributing to organ homeostasis. While fulfilling important repair functions during tissue regeneration upon wounding, chronic fibroblast activation provokes pathological organ fibrosis and promotes neoplastic disease progression. Identifying targets that may serve to therapeutically terminate fibroblast activation is therefore desirable. Among the mediators that may be relevant in this context is the prostanoid prostaglandin E2 (PGE2) that is produced during inflammatory settings, where pathological fibrosis occurs. Here, we summarize current, in part controversial, concepts on the impact of PGE2 on fibroblast activation in fibrotic diseases including cancer, and discuss these findings in the context of the evolving concept of fibroblast heterogeneity. |
|---|---|
| AbstractList | Fibroblasts are the essential cellular architects of connective tissue and as such are crucial cells in contributing to organ homeostasis. While fulfilling important repair functions during tissue regeneration upon wounding, chronic fibroblast activation provokes pathological organ fibrosis and promotes neoplastic disease progression. Identifying targets that may serve to therapeutically terminate fibroblast activation is therefore desirable. Among the mediators that may be relevant in this context is the prostanoid prostaglandin E2 (PGE2) that is produced during inflammatory settings, where pathological fibrosis occurs. Here, we summarize current, in part controversial, concepts on the impact of PGE2 on fibroblast activation in fibrotic diseases including cancer, and discuss these findings in the context of the evolving concept of fibroblast heterogeneity.Fibroblasts are the essential cellular architects of connective tissue and as such are crucial cells in contributing to organ homeostasis. While fulfilling important repair functions during tissue regeneration upon wounding, chronic fibroblast activation provokes pathological organ fibrosis and promotes neoplastic disease progression. Identifying targets that may serve to therapeutically terminate fibroblast activation is therefore desirable. Among the mediators that may be relevant in this context is the prostanoid prostaglandin E2 (PGE2) that is produced during inflammatory settings, where pathological fibrosis occurs. Here, we summarize current, in part controversial, concepts on the impact of PGE2 on fibroblast activation in fibrotic diseases including cancer, and discuss these findings in the context of the evolving concept of fibroblast heterogeneity. •Fibroblasts are the main cells of connective tissue and participate in wound repair upon activation.•Unchecked fibroblast activation leads to fibrosis and contributes to cancer development.•PGE2 restricts fibroblast activation in fibrosis, thereby acting in an anti-fibrotic manner.•While PGE2 is considered a tumor-promoting lipid, its role in cancer-associated fibroblast activation is unclear. Fibroblasts are the essential cellular architects of connective tissue and as such are crucial cells in contributing to organ homeostasis. While fulfilling important repair functions during tissue regeneration upon wounding, chronic fibroblast activation provokes pathological organ fibrosis and promotes neoplastic disease progression. Identifying targets that may serve to therapeutically terminate fibroblast activation is therefore desirable. Among the mediators that may be relevant in this context is the prostanoid prostaglandin E2 (PGE2) that is produced during inflammatory settings, where pathological fibrosis occurs. Here, we summarize current, in part controversial, concepts on the impact of PGE2 on fibroblast activation in fibrotic diseases including cancer, and discuss these findings in the context of the evolving concept of fibroblast heterogeneity. |
| ArticleNumber | 106339 |
| Author | Weigert, Andreas Elwakeel, Eiman Brüne, Bernhard |
| Author_xml | – sequence: 1 givenname: Eiman surname: Elwakeel fullname: Elwakeel, Eiman organization: Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany – sequence: 2 givenname: Bernhard surname: Brüne fullname: Brüne, Bernhard organization: Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany – sequence: 3 givenname: Andreas surname: Weigert fullname: Weigert, Andreas email: weigert@biochem.uni-frankfurt.de organization: Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany |
| BookMark | eNqNkEtPwkAUhWeBiYD-hy5cuCnOo0DHuPARQBISXeh6cnt7i0PKFDsDif_ewbrRFau7uOc7yfkGrOcaR4xdCT4SXExuNqNd2_gA6xpcaZ0fSS50fE2U0j3WF1znaZ5Ldc4G3m84j2_B--z-dTGTiXVJZYvIW59EPEFwSO1tsnTerj-Cj4HQdJGiBh8SwGAPEGzjLthZBbWny987ZO_z2dvTc7p6WSyfHlYpKiV1Kol4PgWOKKdlLrKikqUsBOBYI1ZUABUcUBFUAJqKSoEGnGYkMNMw1loN2XXXG2d-7skHs7UeqY5zqdl7I6WSfCxVxmP0rotiXORbqsyutVtov4zg5ijLbMxfWeYoy3SyIv74D0cbfraGFmx9asm8K6Ho5GCpNR4tRaulbQmDKRt7WtE3u1uYCg |
| CitedBy_id | crossref_primary_10_3389_fphar_2025_1598009 crossref_primary_10_1007_s11010_024_05134_6 crossref_primary_10_3389_fphar_2023_1068849 crossref_primary_10_1186_s12967_023_04392_0 crossref_primary_10_3390_ijms21165786 crossref_primary_10_1158_0008_5472_CAN_21_2116 crossref_primary_10_3390_biom11060789 crossref_primary_10_3389_fphar_2022_840440 crossref_primary_10_3390_cells10071653 crossref_primary_10_3390_biomedicines8120565 crossref_primary_10_1007_s11033_022_07924_x crossref_primary_10_1016_j_scr_2020_101831 crossref_primary_10_3389_fcvm_2022_1011176 crossref_primary_10_1002_1878_0261_13502 crossref_primary_10_3389_fcell_2023_1257751 crossref_primary_10_3390_ijms20246254 crossref_primary_10_1186_s12964_023_01268_0 crossref_primary_10_3390_ijms222111636 crossref_primary_10_1007_s00018_025_05800_y crossref_primary_10_1124_jpet_120_000103 |
| Cites_doi | 10.1016/j.celrep.2017.08.098 10.1126/science.1209200 10.1016/j.prostaglandins.2013.09.001 10.1016/j.imbio.2012.05.001 10.1093/rheumatology/keu288 10.1152/ajplung.00489.2006 10.1038/nm.2807 10.1038/s41467-018-07582-3 10.1093/rheumatology/keq275 10.1073/pnas.96.13.7220 10.1165/rcmb.2014-0468OC 10.1016/S0021-9258(18)53022-2 10.1007/s00418-008-0464-1 10.1016/j.tcb.2014.10.001 10.1074/jbc.M114.558130 10.1073/pnas.0914295107 10.1016/j.prostaglandins.2014.09.002 10.1152/physiolgenomics.00086.2017 10.1002/path.2277 10.1080/10937404.2011.556047 10.1096/fj.08-128801 10.1172/JCI112364 10.1536/ihj.16-200 10.1074/jbc.M003504200 10.1083/jcb.122.1.103 10.1158/0008-5472.CAN-12-4150 10.1016/S0021-9258(20)80710-8 10.1194/jlr.M019695 10.1016/S1937-6448(09)76004-6 10.1038/s41598-018-21889-7 10.1165/ajrcmb.22.5.3948 10.1158/1541-7786.MCR-12-0307 10.1016/j.retram.2016.09.003 10.1007/s00277-001-0410-y 10.1038/nrc2809 10.3389/fonc.2014.00062 10.1038/nri.2017.90 10.1007/s00281-012-0342-8 10.1172/JCI93557 10.1016/j.prostaglandins.2015.06.002 10.1172/JCI93563 10.1158/1541-7786.MCR-15-0307 10.1016/S0014-5793(02)03413-0 10.1165/rcmb.4857 10.1073/pnas.1424355112 10.1016/j.pupt.2017.03.016 10.1038/nrc1877 10.1056/NEJM199902113400604 10.1016/j.molmed.2013.05.004 10.1002/jcp.25879 10.4049/jimmunol.174.9.5644 10.1016/S0090-6980(02)00050-3 10.1007/s00395-012-0319-8 10.1124/jpet.111.189845 10.1016/j.plefa.2011.01.003 10.1093/humupd/dmv026 10.1016/j.bbalip.2009.01.021 10.1016/j.ccr.2014.04.021 10.1126/science.1171362 10.1194/jlr.R800094-JLR200 10.1186/1471-2407-14-186 10.1111/exd.13014 10.1126/sciadv.aar8320 10.1016/j.semcancer.2013.12.005 10.1016/j.tips.2006.06.001 10.1111/j.1476-5381.2008.00051.x 10.1016/j.drudis.2016.08.003 10.1172/JCI93555 10.1172/JCI93554 10.1016/j.ccr.2014.04.005 10.1165/rcmb.2002-0243OC 10.1038/ni1276 10.1084/jem.20162024 10.4049/jimmunol.148.7.2142 10.1038/nri3859 10.1016/j.plipres.2017.04.003 10.1007/s10555-008-9173-4 10.1007/s10555-018-9731-3 10.1074/jbc.M003505200 10.1016/j.mam.2018.06.003 10.1161/ATVBAHA.110.207449 10.1186/bcr1831 10.1016/j.ebiom.2018.05.008 10.1016/j.ejphar.2016.12.004 10.1038/nrc.2016.73 10.1016/j.bbalip.2012.07.022 10.1016/j.yexcr.2010.04.032 10.1016/j.jaci.2014.11.001 10.1006/bbrc.2002.6531 10.1016/j.cell.2016.01.009 10.1016/j.imlet.2014.03.001 10.1002/jcp.25412 10.1172/JCI117866 10.1186/s13075-016-0929-x 10.1016/j.matbio.2017.01.002 10.1152/ajplung.00232.2006 10.4049/jimmunol.1101029 10.1186/s13058-014-0410-1 10.1007/s00210-008-0334-3 10.1056/NEJM198612253152606 10.1158/0008-5472.CAN-16-0176 10.1007/s00441-016-2431-9 10.1002/ijc.28181 10.1165/rcmb.2008-0080OC 10.1513/AnnalsATS.201606-426FR 10.1038/bjc.1995.523 10.1038/nrm809 10.4049/jimmunol.175.10.6924 10.1016/j.canlet.2011.12.020 |
| ContentType | Journal Article |
| Copyright | 2019 Elsevier Inc. Copyright © 2019 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2019 Elsevier Inc. – notice: Copyright © 2019 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION 7X8 |
| DOI | 10.1016/j.prostaglandins.2019.106339 |
| DatabaseName | CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| ExternalDocumentID | 10_1016_j_prostaglandins_2019_106339 S1098882319300231 |
| GroupedDBID | --- --K --M .GJ .~1 0R~ 123 1B1 1RT 1~. 1~5 29P 3O- 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABFRF ABGSF ABMAC ABOCM ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FGOYB FIRID FNPLU FYGXN GBLVA HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SES SEW SPCBC SSU SSZ T5K UHS UNMZH ZGI ZXP ~G- ~KM 9DU AATTM AAXKI AAYWO AAYXX ABJNI ABWVN ACLOT ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS ~HD 7X8 |
| ID | FETCH-LOGICAL-c3329-2ee087a0cc27d814bf2d2b1ac59ccfebaeb0ac3eafaa9ebf3a9ac74e1c49a5993 |
| ISSN | 1098-8823 |
| IngestDate | Wed Oct 01 14:59:30 EDT 2025 Sat Nov 29 06:33:03 EST 2025 Tue Nov 18 22:30:59 EST 2025 Fri Feb 23 02:27:21 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | PGE2 mPGES-1 COX Fibrosis Cancer |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c3329-2ee087a0cc27d814bf2d2b1ac59ccfebaeb0ac3eafaa9ebf3a9ac74e1c49a5993 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://hdl.handle.net/1721.1/150660 |
| PQID | 2232052340 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2232052340 crossref_primary_10_1016_j_prostaglandins_2019_106339 crossref_citationtrail_10_1016_j_prostaglandins_2019_106339 elsevier_sciencedirect_doi_10_1016_j_prostaglandins_2019_106339 |
| PublicationCentury | 2000 |
| PublicationDate | August 2019 2019-08-00 20190801 |
| PublicationDateYYYYMMDD | 2019-08-01 |
| PublicationDate_xml | – month: 08 year: 2019 text: August 2019 |
| PublicationDecade | 2010 |
| PublicationTitle | Prostaglandins & other lipid mediators |
| PublicationYear | 2019 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Talman, Ruskoaho (bib0430) 2016; 365 Chen, Li, Kuo, Tsai, Hou, Hung (bib0530) 2014; 16 O’Reilly (bib0210) 2016; 18 Loynes, Lee, Robertson, Steel, Ellett, Feng, Levy, Whyte, Renshaw (bib0045) 2018; 4 Penke, Huang, White, Peters-Golden (bib0415) 2014; 289 Smyth, Grosser, Wang, Yu, FitzGerald (bib0040) 2009; 50 Gerarduzzi, He, Zhai, Antoniou, Di Battista (bib0455) 2017; 232 Leclerc, Idborg, Spahiu, Larsson, Nekhotiaeva, Wannberg, Stenberg, Korotkova, Jakobsson (bib0480) 2013; 107 He, LaPointe, Harding (bib0440) 2011; 25 Wettlaufer, Scott, McEachin, Peters-Golden, Huang (bib0410) 2016; 54 Madar, Goldstein, Rotter (bib0280) 2013; 19 Murakami, Naraba, Tanioka, Semmyo, Nakatani, Kojima, Ikeda, Fueki, Ueno, Oh, Kudo (bib0085) 2000; 275 Huang, Wettlaufer, Chung, Peters-Golden (bib0420) 2008; 39 Weigert, Strack, Snodgrass, Brune (bib0485) 2018; 37 Volkmann, Tashkin (bib0225) 2016; 13 Rhim, Oberstein, Thomas, Mirek, Palermo, Sastra, Dekleva, Saunders, Becerra, Tattersall, Westphalen, Kitajewski, Fernandez-Barrena, Fernandez-Zapico, Iacobuzio-Donahue, Olive, Stanger (bib0340) 2014; 25 Larsson, Kock, Idborg, Arsenian Henriksson, Martinsson, Johnsen, Korotkova, Kogner, Jakobsson (bib0515) 2015; 112 Brucher, Lyman, van Hillegersberg, Pollock, Lordick, Yang, Ushijima, Yeoh, Skricka, Polkowski, Wallner, Verwaal, Garofalo, D’Ugo, Roviello, Steinau, Wallace, Daumer, Maihle, Reid, Ducreux, Kitagawa, Knuth, Zilberstein, Steele, Jamall (bib0230) 2014; 14 Honegger, Hofer, Baranao, Mackinlay, Mackinlay, Bullorsky, Bordenave, Chasseing (bib0525) 2002; 81 Honda, Sugimoto, Namba, Watabe, Irie, Negishi, Narumiya, Ichikawa (bib0110) 1993; 268 Jakobsson, Thoren, Morgenstern, Samuelsson (bib0075) 1999; 96 Wang, Dubois (bib0490) 2010; 10 Israel, Regan (bib0115) 2009; 1791 Nomura, Morrison, Blankman, Long, Kinsey, Marcondes, Ward, Hahn, Lichtman, Conti, Cravatt (bib0090) 2011; 334 Thomas, Peters-Golden, White, Thannickal, Moore (bib0425) 2007; 293 Guerra, Odorisio, Zambruno, Castiglia (bib0245) 2017; 63 Huang, Wettlaufer, Hogaboam, Aronoff, Peters-Golden (bib0550) 2007; 292 Wynn, Ramalingam (bib0190) 2012; 18 Li, Yang, Hua, Wang, Liu, Jia, Tai, Zhang, Chen (bib0535) 2012; 318 Gomez, Pillinger, Attur, Marjanovic, Dave, Park, Bingham, Al-Mussawir, Abramson (bib0460) 2005; 175 Sha, Olesch, Hanaka, Radmark, Weigert, Brune (bib0370) 2013; 133 Rasanen, Vaheri (bib0290) 2010; 316 Tai, Ensor, Tong, Zhou, Yan (bib0125) 2002; 68–69 De Wever, Pauwels, De Craene, Sabbah, Emami, Redeuilh, Gespach, Bracke, Berx (bib0300) 2008; 130 Kalluri, Zeisberg (bib0355) 2006; 6 Larsson, Jakobsson (bib0140) 2015; 120 Driskell, Watt (bib0150) 2015; 25 Olive, Jacobetz, Davidson, Gopinathan, McIntyre, Honess, Madhu, Goldgraben, Caldwell, Allard, Frese, Denicola, Feig, Combs, Winter, Ireland-Zecchini, Reichelt, Howat, Chang, Dhara, Wang, Ruckert, Grutzmann, Pilarsky, Izeradjene, Hingorani, Huang, Davies, Plunkett, Egorin, Hruban, Whitebread, McGovern, Adams, Iacobuzio-Donahue, Griffiths, Tuveson (bib0285) 2009; 324 Bartoschek, Oskolkov, Bocci, Lövrot, Larsson, Sommarin, Madsen, Lindgren, Pekar, Karlsson, Ringnér, Bergh, Björklund, Pietras (bib0350) 2018; 9 Kalinski (bib0015) 2012; 188 Grugan, Miller, Yao, Michaylira, Ohashi, Klein-Szanto, Diehl, Herlyn, Han, Nakagawa, Rustgi (bib0295) 2010; 107 Ricciotti, FitzGerald (bib0020) 2011; 31 Kumar, Weaver (bib0325) 2009; 28 Harding, LaPointe (bib0465) 2011; 84 Iwanaga, Okada, Murata, Hori, Ozaki (bib0470) 2012; 340 Sha, Brune, Weigert (bib0495) 2012; 217 Haag, Warnken, Juergens, Racke (bib0545) 2008; 378 Kalluri (bib0035) 2016; 16 Schwalm, Pfeilschifter, Huwiler (bib0195) 2013; 1831 Desmouliere, Geinoz, Gabbiani, Gabbiani (bib0165) 1993; 122 Alcolea, Anton, Camacho, Soler, Alfranca, Aviles-Jurado, Redondo, Quer, Leon, Vila (bib0510) 2012; 53 Serhan, Savill (bib0010) 2005; 6 Annunziato, Romagnani, Romagnani (bib0365) 2015; 135 Karampitsakos, Tzilas, Tringidou, Steiropoulos, Aidinis, Papiris, Bouros, Tzouvelekis (bib0255) 2017; 45 Moreno (bib0120) 2017; 796 Jacobs, Byrne, Colditz, Connolly, Schnitt (bib0240) 1999; 340 Yamauchi, Barker, Gibbons, Kurie (bib0275) 2018; 128 Kock, Larsson, Bergqvist, Eissler, Elfman, Raouf, Korotkova, Johnsen, Jakobsson, Kogner (bib0520) 2018; 32 Huang, White, Wettlaufer, Grifka, Hogaboam, Thannickal, Horowitz, Peters-Golden (bib0400) 2009; 23 Augsten (bib0315) 2014; 4 Wang, Oka, Yamagami, Lee, Akazawa, Naito, Yasui, Ishizu, Nakaoka, Sakata, Komuro (bib0445) 2017; 58 Seo, Oh (bib0065) 2017; 66 Harper, Sainson (bib0305) 2014; 25 Schrey, Patel (bib0500) 1995; 72 Bitterman, Wewers, Rennard, Adelberg, Crystal (bib0390) 1986; 77 Karagiannis, Poutahidis, Erdman, Kirsch, Riddell, Diamandis (bib0265) 2012; 10 Kassem, Clevenger, Szandzik, Peterson, Harding (bib0435) 2014; 113–115 Tanioka, Nakatani, Semmyo, Murakami, Kudo (bib0070) 2000; 275 Watabe, Sugimoto, Honda, Irie, Namba, Negishi, Ito, Narumiya, Ichikawa (bib0105) 1993; 268 Wynn (bib0180) 2008; 214 Kolodsick, Peters-Golden, Larios, Toews, Thannickal, Moore (bib0405) 2003; 29 Vancheri, Sortino, Tomaselli, Mastruzzo, Condorelli, Bellistri, Pistorio, Canonico, Crimi (bib0385) 2000; 22 Lynch, Watt (bib0155) 2018; 128 Fromel, Kohlstedt, Popp, Yin, Awwad, Barbosa-Sicard, Thomas, Lieberz, Mayr, Fleming (bib0130) 2013; 108 Martin, Boyd (bib0235) 2008; 10 David, Huang, Chen, Su, Zou, Bardeesy, Iacobuzio-Donahue, Massague (bib0270) 2016; 164 Costea, Hills, Osman, Thurlow, Kalna, Huang, Pena Murillo, Parajuli, Suliman, Kulasekara, Johannessen, Partridge (bib0345) 2013; 73 Moore, Ballinger, White, Green, Herrygers, Wilke, Toews, Peters-Golden (bib0555) 2005; 174 Gieseck, Wilson, Wynn (bib0360) 2018; 18 Markovic, Jakopin, Dolenc, Mlinaric-Rascan (bib0095) 2017; 22 Balsinde, Winstead, Dennis (bib0055) 2002; 531 Ozdemir, Pentcheva-Hoang, Carstens, Zheng, Wu, Simpson, Laklai, Sugimoto, Kahlert, Novitskiy, De Jesus-Acosta, Sharma, Heidari, Mahmood, Chin, Moses, Weaver, Maitra, Allison, LeBleu, Kalluri (bib0335) 2014; 25 Dennis, Norris (bib0005) 2015; 15 Duffy (bib0100) 2015; 21 Jun, Lau (bib0175) 2018; 128 Ohlund, Handly-Santana, Biffi, Elyada, Almeida, Ponz-Sarvise, Corbo, Oni, Hearn, Lee, Chio, Hwang, Tiriac, Baker, Engle, Feig, Kultti, Egeblad, Fearon, Crawford, Clevers, Park, Tuveson (bib0320) 2017; 214 Scholich, Geisslinger (bib0145) 2006; 27 Newson, Motwani, Kendall, Nicolaou, Muccioli, Alhouayek, Bennett, Van De Merwe, James, De Maeyer, Gilroy (bib0050) 2017; 20 Rodriguez, Emblom-Callahan, Chhina, Bui, Aljeburry, Tran, Novak, Lemma, Nathan, Grant (bib0540) 2018; 8 Ayabe, Murata, Maruyama, Hori, Ozaki (bib0475) 2009; 156 Lama, Moore, Christensen, Toews, Peters-Golden (bib0395) 2002; 27 Dvorak (bib0260) 1986; 315 Weiskirchen, Weiskirchen, Tacke (bib0200) 2019; 65 Carthy (bib0160) 2018; 233 Mossman, Lippmann, Hesterberg, Kelsey, Barchowsky, Bonner (bib0250) 2011; 14 Poggi, Musso, Dapino, Zocchi (bib0310) 2014; 159 Khanna, Furst, Allanore, Bae, Bodukam, Clements, Cutolo, Czirjak, Denton, Distler, Walker, Matucci-Cerinic, Muller-Ladner, Seibold, Singh, Tyndall (bib0220) 2015; 54 Shima, Kuwahara, Murota, Kitaba, Kawai, Hirano, Arimitsu, Narazaki, Hagihara, Ogata, Katayama, Kawase, Kishimoto, Tanaka (bib0215) 2010; 49 Herrera, Henke, Bitterman (bib0205) 2018; 128 White, Stevenson (bib0135) 2018; 379 Tomasek, Gabbiani, Hinz, Chaponnier, Brown (bib0170) 2002; 3 Maggi, Parronchi, Manetti, Simonelli, Piccinni, Rugiu, De Carli, Ricci, Romagnani (bib0375) 1992; 148 Tanikawa, Ohmiya, Ohkubo, Hashimoto, Kangawa, Kojima, Ito, Watanabe (bib0080) 2002; 291 Wilborn, Crofford, Burdick, Kunkel, Strieter, Peters-Golden (bib0380) 1995; 95 Nakanishi, Rosenberg (bib0025) 2013; 35 Sorrell, Caplan (bib0030) 2009; 276 Zhao, Shu, Chen, Tang, Zhang, Xie, Liu, Xu, Qi (bib0450) 2016; 25 Alba-Castellon, Olivera-Salguero, Mestre-Farrera, Pena, Herrera, Bonilla, Casal, Baulida, Pena, Garcia de Herreros (bib0505) 2016; 76 Alexanian, Sorokin (bib0060) 2017; 49 Hinz (bib0185) 2016; 64 Pankova, Chen, Terajima, Schliekelman, Baird, Fahrenholtz, Sun, Gill, Vadakkan, Kim, Ahn, Roybal, Liu, Parra Cuentas, Rodriguez, Wistuba, Creighton, Gibbons, Hicks, Dickinson, West, Grande-Allen, Hanash, Yamauchi, Kurie (bib0330) 2016; 14 Jakobsson (10.1016/j.prostaglandins.2019.106339_bib0075) 1999; 96 Thomas (10.1016/j.prostaglandins.2019.106339_bib0425) 2007; 293 Dennis (10.1016/j.prostaglandins.2019.106339_bib0005) 2015; 15 Kumar (10.1016/j.prostaglandins.2019.106339_bib0325) 2009; 28 Bartoschek (10.1016/j.prostaglandins.2019.106339_bib0350) 2018; 9 Desmouliere (10.1016/j.prostaglandins.2019.106339_bib0165) 1993; 122 Wang (10.1016/j.prostaglandins.2019.106339_bib0445) 2017; 58 Ozdemir (10.1016/j.prostaglandins.2019.106339_bib0335) 2014; 25 Fromel (10.1016/j.prostaglandins.2019.106339_bib0130) 2013; 108 Shima (10.1016/j.prostaglandins.2019.106339_bib0215) 2010; 49 Nakanishi (10.1016/j.prostaglandins.2019.106339_bib0025) 2013; 35 Sha (10.1016/j.prostaglandins.2019.106339_bib0495) 2012; 217 Guerra (10.1016/j.prostaglandins.2019.106339_bib0245) 2017; 63 Khanna (10.1016/j.prostaglandins.2019.106339_bib0220) 2015; 54 Smyth (10.1016/j.prostaglandins.2019.106339_bib0040) 2009; 50 Murakami (10.1016/j.prostaglandins.2019.106339_bib0085) 2000; 275 Rhim (10.1016/j.prostaglandins.2019.106339_bib0340) 2014; 25 Ohlund (10.1016/j.prostaglandins.2019.106339_bib0320) 2017; 214 Annunziato (10.1016/j.prostaglandins.2019.106339_bib0365) 2015; 135 Wettlaufer (10.1016/j.prostaglandins.2019.106339_bib0410) 2016; 54 Honegger (10.1016/j.prostaglandins.2019.106339_bib0525) 2002; 81 Olive (10.1016/j.prostaglandins.2019.106339_bib0285) 2009; 324 Poggi (10.1016/j.prostaglandins.2019.106339_bib0310) 2014; 159 Nomura (10.1016/j.prostaglandins.2019.106339_bib0090) 2011; 334 Gieseck (10.1016/j.prostaglandins.2019.106339_bib0360) 2018; 18 Scholich (10.1016/j.prostaglandins.2019.106339_bib0145) 2006; 27 Tai (10.1016/j.prostaglandins.2019.106339_bib0125) 2002; 68–69 Zhao (10.1016/j.prostaglandins.2019.106339_bib0450) 2016; 25 Tanioka (10.1016/j.prostaglandins.2019.106339_bib0070) 2000; 275 O’Reilly (10.1016/j.prostaglandins.2019.106339_bib0210) 2016; 18 Ricciotti (10.1016/j.prostaglandins.2019.106339_bib0020) 2011; 31 Kalluri (10.1016/j.prostaglandins.2019.106339_bib0355) 2006; 6 Jacobs (10.1016/j.prostaglandins.2019.106339_bib0240) 1999; 340 White (10.1016/j.prostaglandins.2019.106339_bib0135) 2018; 379 Loynes (10.1016/j.prostaglandins.2019.106339_bib0045) 2018; 4 Rodriguez (10.1016/j.prostaglandins.2019.106339_bib0540) 2018; 8 Schrey (10.1016/j.prostaglandins.2019.106339_bib0500) 1995; 72 Pankova (10.1016/j.prostaglandins.2019.106339_bib0330) 2016; 14 Weigert (10.1016/j.prostaglandins.2019.106339_bib0485) 2018; 37 Larsson (10.1016/j.prostaglandins.2019.106339_bib0515) 2015; 112 Serhan (10.1016/j.prostaglandins.2019.106339_bib0010) 2005; 6 Harper (10.1016/j.prostaglandins.2019.106339_bib0305) 2014; 25 De Wever (10.1016/j.prostaglandins.2019.106339_bib0300) 2008; 130 Martin (10.1016/j.prostaglandins.2019.106339_bib0235) 2008; 10 Brucher (10.1016/j.prostaglandins.2019.106339_bib0230) 2014; 14 Balsinde (10.1016/j.prostaglandins.2019.106339_bib0055) 2002; 531 Maggi (10.1016/j.prostaglandins.2019.106339_bib0375) 1992; 148 Duffy (10.1016/j.prostaglandins.2019.106339_bib0100) 2015; 21 Herrera (10.1016/j.prostaglandins.2019.106339_bib0205) 2018; 128 Li (10.1016/j.prostaglandins.2019.106339_bib0535) 2012; 318 Haag (10.1016/j.prostaglandins.2019.106339_bib0545) 2008; 378 Kolodsick (10.1016/j.prostaglandins.2019.106339_bib0405) 2003; 29 Moreno (10.1016/j.prostaglandins.2019.106339_bib0120) 2017; 796 He (10.1016/j.prostaglandins.2019.106339_bib0440) 2011; 25 Ayabe (10.1016/j.prostaglandins.2019.106339_bib0475) 2009; 156 Yamauchi (10.1016/j.prostaglandins.2019.106339_bib0275) 2018; 128 Kock (10.1016/j.prostaglandins.2019.106339_bib0520) 2018; 32 Watabe (10.1016/j.prostaglandins.2019.106339_bib0105) 1993; 268 Sorrell (10.1016/j.prostaglandins.2019.106339_bib0030) 2009; 276 Alba-Castellon (10.1016/j.prostaglandins.2019.106339_bib0505) 2016; 76 Kalluri (10.1016/j.prostaglandins.2019.106339_bib0035) 2016; 16 Kassem (10.1016/j.prostaglandins.2019.106339_bib0435) 2014; 113–115 Karagiannis (10.1016/j.prostaglandins.2019.106339_bib0265) 2012; 10 Costea (10.1016/j.prostaglandins.2019.106339_bib0345) 2013; 73 Huang (10.1016/j.prostaglandins.2019.106339_bib0420) 2008; 39 Moore (10.1016/j.prostaglandins.2019.106339_bib0555) 2005; 174 Huang (10.1016/j.prostaglandins.2019.106339_bib0400) 2009; 23 Hinz (10.1016/j.prostaglandins.2019.106339_bib0185) 2016; 64 Iwanaga (10.1016/j.prostaglandins.2019.106339_bib0470) 2012; 340 Schwalm (10.1016/j.prostaglandins.2019.106339_bib0195) 2013; 1831 Grugan (10.1016/j.prostaglandins.2019.106339_bib0295) 2010; 107 Madar (10.1016/j.prostaglandins.2019.106339_bib0280) 2013; 19 Harding (10.1016/j.prostaglandins.2019.106339_bib0465) 2011; 84 Kalinski (10.1016/j.prostaglandins.2019.106339_bib0015) 2012; 188 Wynn (10.1016/j.prostaglandins.2019.106339_bib0190) 2012; 18 Wang (10.1016/j.prostaglandins.2019.106339_bib0490) 2010; 10 Honda (10.1016/j.prostaglandins.2019.106339_bib0110) 1993; 268 Carthy (10.1016/j.prostaglandins.2019.106339_bib0160) 2018; 233 Tanikawa (10.1016/j.prostaglandins.2019.106339_bib0080) 2002; 291 Jun (10.1016/j.prostaglandins.2019.106339_bib0175) 2018; 128 Vancheri (10.1016/j.prostaglandins.2019.106339_bib0385) 2000; 22 Leclerc (10.1016/j.prostaglandins.2019.106339_bib0480) 2013; 107 Gomez (10.1016/j.prostaglandins.2019.106339_bib0460) 2005; 175 Chen (10.1016/j.prostaglandins.2019.106339_bib0530) 2014; 16 Lynch (10.1016/j.prostaglandins.2019.106339_bib0155) 2018; 128 Volkmann (10.1016/j.prostaglandins.2019.106339_bib0225) 2016; 13 David (10.1016/j.prostaglandins.2019.106339_bib0270) 2016; 164 Larsson (10.1016/j.prostaglandins.2019.106339_bib0140) 2015; 120 Seo (10.1016/j.prostaglandins.2019.106339_bib0065) 2017; 66 Karampitsakos (10.1016/j.prostaglandins.2019.106339_bib0255) 2017; 45 Augsten (10.1016/j.prostaglandins.2019.106339_bib0315) 2014; 4 Wilborn (10.1016/j.prostaglandins.2019.106339_bib0380) 1995; 95 Mossman (10.1016/j.prostaglandins.2019.106339_bib0250) 2011; 14 Rasanen (10.1016/j.prostaglandins.2019.106339_bib0290) 2010; 316 Markovic (10.1016/j.prostaglandins.2019.106339_bib0095) 2017; 22 Huang (10.1016/j.prostaglandins.2019.106339_bib0550) 2007; 292 Lama (10.1016/j.prostaglandins.2019.106339_bib0395) 2002; 27 Newson (10.1016/j.prostaglandins.2019.106339_bib0050) 2017; 20 Gerarduzzi (10.1016/j.prostaglandins.2019.106339_bib0455) 2017; 232 Alcolea (10.1016/j.prostaglandins.2019.106339_bib0510) 2012; 53 Talman (10.1016/j.prostaglandins.2019.106339_bib0430) 2016; 365 Dvorak (10.1016/j.prostaglandins.2019.106339_bib0260) 1986; 315 Alexanian (10.1016/j.prostaglandins.2019.106339_bib0060) 2017; 49 Driskell (10.1016/j.prostaglandins.2019.106339_bib0150) 2015; 25 Sha (10.1016/j.prostaglandins.2019.106339_bib0370) 2013; 133 Bitterman (10.1016/j.prostaglandins.2019.106339_bib0390) 1986; 77 Tomasek (10.1016/j.prostaglandins.2019.106339_bib0170) 2002; 3 Israel (10.1016/j.prostaglandins.2019.106339_bib0115) 2009; 1791 Wynn (10.1016/j.prostaglandins.2019.106339_bib0180) 2008; 214 Weiskirchen (10.1016/j.prostaglandins.2019.106339_bib0200) 2019; 65 Penke (10.1016/j.prostaglandins.2019.106339_bib0415) 2014; 289 |
| References_xml | – volume: 84 start-page: 147 year: 2011 end-page: 152 ident: bib0465 article-title: Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor publication-title: Prostaglandins Leukot. Essent. Fatty Acids – volume: 10 start-page: 1403 year: 2012 end-page: 1418 ident: bib0265 article-title: Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue publication-title: Mol. Cancer Res. – volume: 25 start-page: 719 year: 2014 end-page: 734 ident: bib0335 article-title: Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival publication-title: Cancer Cell – volume: 45 start-page: 1 year: 2017 end-page: 10 ident: bib0255 article-title: Lung cancer in patients with idiopathic pulmonary fibrosis publication-title: Pulm. Pharmacol. Ther. – volume: 76 start-page: 6205 year: 2016 end-page: 6217 ident: bib0505 article-title: Snail1-dependent activation of cancer-associated fibroblast controls epithelial tumor cell invasion and metastasis publication-title: Cancer Res. – volume: 340 start-page: 430 year: 1999 end-page: 436 ident: bib0240 article-title: Radial scars in benign breast-biopsy specimens and the risk of breast cancer publication-title: N. Engl. J. Med. – volume: 73 start-page: 3888 year: 2013 end-page: 3901 ident: bib0345 article-title: Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma publication-title: Cancer Res. – volume: 96 start-page: 7220 year: 1999 end-page: 7225 ident: bib0075 article-title: Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 120 start-page: 161 year: 2015 end-page: 165 ident: bib0140 article-title: Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment publication-title: Prostaglandins Other Lipid Mediat. – volume: 107 start-page: 11026 year: 2010 end-page: 11031 ident: bib0295 article-title: Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 6 start-page: 392 year: 2006 end-page: 401 ident: bib0355 article-title: Fibroblasts in cancer publication-title: Nat. Rev. Cancer – volume: 122 start-page: 103 year: 1993 end-page: 111 ident: bib0165 article-title: Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts publication-title: J. Cell Biol. – volume: 19 start-page: 447 year: 2013 end-page: 453 ident: bib0280 article-title: ’Cancer associated fibroblasts’—more than meets the eye publication-title: Trends Mol. Med. – volume: 531 start-page: 2 year: 2002 end-page: 6 ident: bib0055 article-title: Phospholipase A(2) regulation of arachidonic acid mobilization publication-title: FEBS Lett. – volume: 315 start-page: 1650 year: 1986 end-page: 1659 ident: bib0260 article-title: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing publication-title: N. Engl. J. Med. – volume: 164 start-page: 1015 year: 2016 end-page: 1030 ident: bib0270 article-title: TGF-beta tumor suppression through a lethal EMT publication-title: Cell – volume: 63 start-page: 1 year: 2017 end-page: 10 ident: bib0245 article-title: Stromal microenvironment in type VII collagen-deficient skin: the ground for squamous cell carcinoma development publication-title: Matrix Biol. – volume: 32 start-page: 84 year: 2018 end-page: 92 ident: bib0520 article-title: Inhibition of microsomal prostaglandin e Synthase-1 in cancer-associated fibroblasts suppresses neuroblastoma tumor growth publication-title: EBioMedicine – volume: 378 start-page: 617 year: 2008 end-page: 630 ident: bib0545 article-title: Role of Epac1 in mediating anti-proliferative effects of prostanoid EP(2) receptors and cAMP in human lung fibroblasts publication-title: Naunyn Schmiedebergs Arch. Pharmacol. – volume: 130 start-page: 481 year: 2008 end-page: 494 ident: bib0300 article-title: Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front publication-title: Histochem. Cell Biol. – volume: 379 start-page: 2281 year: 2018 end-page: 2282 ident: bib0135 article-title: Aspirin-exacerbated respiratory disease publication-title: N. Engl. J. Med. – volume: 128 start-page: 97 year: 2018 end-page: 107 ident: bib0175 article-title: Resolution of organ fibrosis publication-title: J. Clin. Invest. – volume: 27 start-page: 399 year: 2006 end-page: 401 ident: bib0145 article-title: Is mPGES-1 a promising target for pain therapy? publication-title: Trends Pharmacol. Sci. – volume: 232 start-page: 202 year: 2017 end-page: 215 ident: bib0455 article-title: Prostaglandin E2-dependent phosphorylation of RAS inhibition 1 (RIN1) at Ser 291 and 292 inhibits transforming growth factor-beta-induced RAS activation pathway in human synovial fibroblasts: role in cell migration publication-title: J. Cell. Physiol. – volume: 39 start-page: 482 year: 2008 end-page: 489 ident: bib0420 article-title: Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1 publication-title: Am. J. Respir. Cell Mol. Biol. – volume: 14 start-page: 76 year: 2011 end-page: 121 ident: bib0250 article-title: Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos publication-title: J. Toxicol. Environ. Health Part B: Crit. Rev. – volume: 13 start-page: 2045 year: 2016 end-page: 2056 ident: bib0225 article-title: Treatment of systemic sclerosis-related interstitial lung disease: a review of existing and emerging therapies publication-title: Ann. Am. Thorac. Soc. – volume: 268 start-page: 7759 year: 1993 end-page: 7762 ident: bib0110 article-title: Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype publication-title: J. Biol. Chem. – volume: 214 start-page: 579 year: 2017 end-page: 596 ident: bib0320 article-title: Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer publication-title: J. Exp. Med. – volume: 27 start-page: 752 year: 2002 end-page: 758 ident: bib0395 article-title: Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent publication-title: Am. J. Respir. Cell Mol. Biol. – volume: 22 start-page: 57 year: 2017 end-page: 71 ident: bib0095 article-title: Structural features of subtype-selective EP receptor modulators publication-title: Drug Discov. Today – volume: 156 start-page: 835 year: 2009 end-page: 845 ident: bib0475 article-title: Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors publication-title: Br. J. Pharmacol. – volume: 318 start-page: 154 year: 2012 end-page: 161 ident: bib0535 article-title: Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO publication-title: Cancer Lett. – volume: 796 start-page: 7 year: 2017 end-page: 19 ident: bib0120 article-title: Eicosanoid receptors: targets for the treatment of disrupted intestinal epithelial homeostasis publication-title: Eur. J. Pharmacol. – volume: 54 start-page: 114 year: 2016 end-page: 127 ident: bib0410 article-title: Reversal of the transcriptome by prostaglandin E2 during myofibroblast dedifferentiation publication-title: Am. J. Respir. Cell Mol. Biol. – volume: 25 year: 2011 ident: bib0440 article-title: PGE2 reduces MMP expression and cell migration in neonatal ventricular fibroblasts publication-title: FASEB J. – volume: 18 start-page: 62 year: 2018 end-page: 76 ident: bib0360 article-title: Type 2 immunity in tissue repair and fibrosis publication-title: Nat. Rev. Immunol. – volume: 50 start-page: S423 year: 2009 end-page: 8 ident: bib0040 article-title: Prostanoids in health and disease publication-title: J. Lipid Res. – volume: 108 start-page: 319 year: 2013 ident: bib0130 article-title: Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques publication-title: Basic Res. Cardiol. – volume: 15 start-page: 511 year: 2015 end-page: 523 ident: bib0005 article-title: Eicosanoid storm in infection and inflammation publication-title: Nat. Rev. Immunol. – volume: 81 start-page: 80 year: 2002 end-page: 85 ident: bib0525 article-title: Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients publication-title: Ann. Hematol. – volume: 324 start-page: 1457 year: 2009 end-page: 1461 ident: bib0285 article-title: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer publication-title: Science – volume: 1791 start-page: 238 year: 2009 end-page: 245 ident: bib0115 article-title: EP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation publication-title: Biochim. Biophys. Acta – volume: 113–115 start-page: 62 year: 2014 end-page: 68 ident: bib0435 article-title: PGE2 reduces MMP-14 and increases plasminogen activator inhibitor-1 in cardiac fibroblasts publication-title: Prostaglandins Other Lipid Mediat. – volume: 25 start-page: 735 year: 2014 end-page: 747 ident: bib0340 article-title: Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma publication-title: Cancer Cell – volume: 68–69 start-page: 483 year: 2002 end-page: 493 ident: bib0125 article-title: Prostaglandin catabolizing enzymes publication-title: Prostaglandins Other Lipid Mediat. – volume: 95 start-page: 1861 year: 1995 end-page: 1868 ident: bib0380 article-title: Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2 publication-title: J. Clin. Invest. – volume: 25 start-page: 69 year: 2014 end-page: 77 ident: bib0305 article-title: Regulation of the anti-tumour immune response by cancer-associated fibroblasts publication-title: Semin. Cancer Biol. – volume: 174 start-page: 5644 year: 2005 end-page: 5649 ident: bib0555 article-title: Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2 publication-title: J. Immunol. – volume: 10 start-page: 201 year: 2008 ident: bib0235 article-title: Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence publication-title: Breast Cancer Res. – volume: 49 start-page: 667 year: 2017 end-page: 681 ident: bib0060 article-title: Cyclooxygenase 2: protein-protein interactions and posttranslational modifications publication-title: Physiol. Genomics – volume: 289 start-page: 17151 year: 2014 end-page: 17162 ident: bib0415 article-title: Prostaglandin E2 inhibits alpha-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A publication-title: J. Biol. Chem. – volume: 128 start-page: 26 year: 2018 end-page: 35 ident: bib0155 article-title: Fibroblast heterogeneity: implications for human disease publication-title: J. Clin. Invest. – volume: 4 start-page: 62 year: 2014 ident: bib0315 article-title: Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment publication-title: Front. Oncol. – volume: 29 start-page: 537 year: 2003 end-page: 544 ident: bib0405 article-title: Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. Prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation publication-title: Am. J. Respir. Cell Mol. Biol. – volume: 133 start-page: 1578 year: 2013 end-page: 1588 ident: bib0370 article-title: Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation publication-title: Int. J. Cancer – volume: 148 start-page: 2142 year: 1992 end-page: 2147 ident: bib0375 article-title: Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones publication-title: J. Immunol. – volume: 340 start-page: 604 year: 2012 end-page: 611 ident: bib0470 article-title: Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation publication-title: J. Pharmacol. Exp. Ther. – volume: 159 start-page: 55 year: 2014 end-page: 72 ident: bib0310 article-title: Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells publication-title: Immunol. Lett. – volume: 77 start-page: 700 year: 1986 end-page: 708 ident: bib0390 article-title: Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators publication-title: J. Clin. Invest. – volume: 365 start-page: 563 year: 2016 end-page: 581 ident: bib0430 article-title: Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration publication-title: Cell Tissue Res. – volume: 10 start-page: 181 year: 2010 end-page: 193 ident: bib0490 article-title: Eicosanoids and cancer publication-title: Nat. Rev. Cancer – volume: 275 start-page: 32775 year: 2000 end-page: 32782 ident: bib0070 article-title: Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis publication-title: J. Biol. Chem. – volume: 291 start-page: 884 year: 2002 end-page: 889 ident: bib0080 article-title: Identification and characterization of a novel type of membrane-associated prostaglandin E synthase publication-title: Biochem. Biophys. Res. Commun. – volume: 22 start-page: 628 year: 2000 end-page: 634 ident: bib0385 article-title: Different expression of TNF-alpha receptors and prostaglandin E(2)Production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process publication-title: Am. J. Respir. Cell Mol. Biol. – volume: 135 start-page: 626 year: 2015 end-page: 635 ident: bib0365 article-title: The 3 major types of innate and adaptive cell-mediated effector immunity publication-title: J. Allergy Clin. Immunol. – volume: 23 start-page: 4317 year: 2009 end-page: 4326 ident: bib0400 article-title: Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways publication-title: FASEB J. – volume: 276 start-page: 161 year: 2009 end-page: 214 ident: bib0030 article-title: Fibroblasts-a diverse population at the center of it all publication-title: Int. Rev. Cell Mol. Biol. – volume: 6 start-page: 1191 year: 2005 end-page: 1197 ident: bib0010 article-title: Resolution of inflammation: the beginning programs the end publication-title: Nat. Immunol. – volume: 233 start-page: 98 year: 2018 end-page: 106 ident: bib0160 article-title: TGFbeta signaling and the control of myofibroblast differentiation: implications for chronic inflammatory disorders publication-title: J. Cell. Physiol. – volume: 3 start-page: 349 year: 2002 ident: bib0170 article-title: Myofibroblasts and mechano-regulation of connective tissue remodelling publication-title: Nat. Rev. Mol. Cell Biol. – volume: 214 start-page: 199 year: 2008 end-page: 210 ident: bib0180 article-title: Cellular and molecular mechanisms of fibrosis publication-title: J. Pathol. – volume: 9 start-page: 5150 year: 2018 ident: bib0350 article-title: Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing publication-title: Nat. Commun. – volume: 21 start-page: 652 year: 2015 end-page: 670 ident: bib0100 article-title: Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway publication-title: Hum. Reprod. Update – volume: 64 start-page: 171 year: 2016 end-page: 177 ident: bib0185 article-title: The role of myofibroblasts in wound healing publication-title: Curr. Res. Transl. Med. – volume: 293 start-page: L417 year: 2007 end-page: 28 ident: bib0425 article-title: PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling publication-title: Am. J. Physiol. Lung Cell. Mol. Physiol. – volume: 268 start-page: 20175 year: 1993 end-page: 20178 ident: bib0105 article-title: Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor publication-title: J. Biol. Chem. – volume: 31 start-page: 986 year: 2011 end-page: 1000 ident: bib0020 article-title: Prostaglandins and inflammation publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 128 start-page: 45 year: 2018 end-page: 53 ident: bib0205 article-title: Extracellular matrix as a driver of progressive fibrosis publication-title: J. Clin. Invest. – volume: 1831 start-page: 239 year: 2013 end-page: 250 ident: bib0195 article-title: Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases publication-title: Biochim. Biophys. Acta – volume: 18 start-page: 11 year: 2016 ident: bib0210 article-title: MicroRNAs in fibrosis: opportunities and challenges publication-title: Arthritis Res. Ther. – volume: 107 start-page: 26 year: 2013 end-page: 34 ident: bib0480 article-title: Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation publication-title: Prostaglandins Other Lipid Mediat. – volume: 217 start-page: 1225 year: 2012 end-page: 1232 ident: bib0495 article-title: The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology publication-title: Immunobiology – volume: 66 start-page: 50 year: 2017 end-page: 68 ident: bib0065 article-title: Prostaglandin synthases: molecular characterization and involvement in prostaglandin biosynthesis publication-title: Prog. Lipid Res. – volume: 4 start-page: eaar8320 year: 2018 ident: bib0045 article-title: PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo publication-title: Sci. Adv. – volume: 16 start-page: 410 year: 2014 ident: bib0530 article-title: Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression publication-title: Breast Cancer Res. – volume: 49 start-page: 2408 year: 2010 end-page: 2412 ident: bib0215 article-title: The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab publication-title: Rheumatology – volume: 35 start-page: 123 year: 2013 end-page: 137 ident: bib0025 article-title: Multifaceted roles of PGE(2) in inflammation and cancer publication-title: Semin. Immunopathol. – volume: 37 start-page: 317 year: 2018 end-page: 334 ident: bib0485 article-title: mPGES-1 and ALOX5/-15 in tumor-associated macrophages publication-title: Cancer Metastasis Rev. – volume: 28 start-page: 113 year: 2009 end-page: 127 ident: bib0325 article-title: Mechanics, malignancy, and metastasis: the force journey of a tumor cell publication-title: Cancer Metastasis Rev. – volume: 16 start-page: 582 year: 2016 end-page: 598 ident: bib0035 article-title: The biology and function of fibroblasts in cancer publication-title: Nat. Rev. Cancer – volume: 20 start-page: 3162 year: 2017 end-page: 3175 ident: bib0050 article-title: Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1/mPGES-1-derived prostaglandin E2 publication-title: Cell Rep. – volume: 112 start-page: 8070 year: 2015 end-page: 8075 ident: bib0515 article-title: COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 8 start-page: 3983 year: 2018 ident: bib0540 article-title: Global gene expression analysis in an in vitro fibroblast model of idiopathic pulmonary fibrosis reveals potential role for CXCL14/CXCR4 publication-title: Sci. Rep. – volume: 188 start-page: 21 year: 2012 end-page: 28 ident: bib0015 article-title: Regulation of immune responses by prostaglandin E2 publication-title: J. Immunol. – volume: 334 start-page: 809 year: 2011 end-page: 813 ident: bib0090 article-title: Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation publication-title: Science – volume: 72 start-page: 1412 year: 1995 end-page: 1419 ident: bib0500 article-title: Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators publication-title: Br. J. Cancer – volume: 25 start-page: 92 year: 2015 end-page: 99 ident: bib0150 article-title: Understanding fibroblast heterogeneity in the skin publication-title: Trends Cell Biol. – volume: 58 start-page: 107 year: 2017 end-page: 114 ident: bib0445 article-title: An EP4 receptor agonist inhibits cardiac fibrosis through activation of PKA signaling in hypertrophied heart publication-title: Int. Heart J. – volume: 175 start-page: 6924 year: 2005 end-page: 6930 ident: bib0460 article-title: Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts publication-title: J. Immunol. – volume: 65 start-page: 2 year: 2019 end-page: 15 ident: bib0200 article-title: Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications publication-title: Mol. Aspects Med. – volume: 275 start-page: 32783 year: 2000 end-page: 32792 ident: bib0085 article-title: Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 publication-title: J. Biol. Chem. – volume: 128 start-page: 16 year: 2018 end-page: 25 ident: bib0275 article-title: The fibrotic tumor stroma publication-title: J. Clin. Invest. – volume: 25 start-page: 604 year: 2016 end-page: 610 ident: bib0450 article-title: Prostaglandin E2 inhibits collagen synthesis in dermal fibroblasts and prevents hypertrophic scar formation in vivo publication-title: Exp. Dermatol. – volume: 292 start-page: L405 year: 2007 end-page: 13 ident: bib0550 article-title: Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. – volume: 14 start-page: 186 year: 2014 ident: bib0230 article-title: Imagine a world without cancer publication-title: BMC Cancer – volume: 18 start-page: 1028 year: 2012 end-page: 1040 ident: bib0190 article-title: Mechanisms of fibrosis: therapeutic translation for fibrotic disease publication-title: Nat. Med. – volume: 316 start-page: 2713 year: 2010 end-page: 2722 ident: bib0290 article-title: Activation of fibroblasts in cancer stroma publication-title: Exp. Cell Res. – volume: 14 start-page: 287 year: 2016 end-page: 295 ident: bib0330 article-title: Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma publication-title: Mol. Cancer Res. – volume: 54 start-page: 144 year: 2015 end-page: 151 ident: bib0220 article-title: Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards publication-title: Rheumatology – volume: 53 start-page: 630 year: 2012 end-page: 642 ident: bib0510 article-title: Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2 publication-title: J. Lipid Res. – volume: 20 start-page: 3162 issue: 13 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0050 article-title: Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1/mPGES-1-derived prostaglandin E2 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.08.098 – volume: 334 start-page: 809 issue: 6057 year: 2011 ident: 10.1016/j.prostaglandins.2019.106339_bib0090 article-title: Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation publication-title: Science doi: 10.1126/science.1209200 – volume: 107 start-page: 26 year: 2013 ident: 10.1016/j.prostaglandins.2019.106339_bib0480 article-title: Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2013.09.001 – volume: 217 start-page: 1225 issue: 12 year: 2012 ident: 10.1016/j.prostaglandins.2019.106339_bib0495 article-title: The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology publication-title: Immunobiology doi: 10.1016/j.imbio.2012.05.001 – volume: 54 start-page: 144 issue: 1 year: 2015 ident: 10.1016/j.prostaglandins.2019.106339_bib0220 article-title: Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards publication-title: Rheumatology doi: 10.1093/rheumatology/keu288 – volume: 293 start-page: L417 issue: 2 year: 2007 ident: 10.1016/j.prostaglandins.2019.106339_bib0425 article-title: PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling publication-title: Am. J. Physiol. Lung Cell. Mol. Physiol. doi: 10.1152/ajplung.00489.2006 – volume: 18 start-page: 1028 issue: 7 year: 2012 ident: 10.1016/j.prostaglandins.2019.106339_bib0190 article-title: Mechanisms of fibrosis: therapeutic translation for fibrotic disease publication-title: Nat. Med. doi: 10.1038/nm.2807 – volume: 9 start-page: 5150 issue: 1 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0350 article-title: Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing publication-title: Nat. Commun. doi: 10.1038/s41467-018-07582-3 – volume: 49 start-page: 2408 issue: 12 year: 2010 ident: 10.1016/j.prostaglandins.2019.106339_bib0215 article-title: The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab publication-title: Rheumatology doi: 10.1093/rheumatology/keq275 – volume: 96 start-page: 7220 issue: 13 year: 1999 ident: 10.1016/j.prostaglandins.2019.106339_bib0075 article-title: Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.96.13.7220 – volume: 54 start-page: 114 issue: 1 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0410 article-title: Reversal of the transcriptome by prostaglandin E2 during myofibroblast dedifferentiation publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/rcmb.2014-0468OC – volume: 25 issue: 1_Suppl year: 2011 ident: 10.1016/j.prostaglandins.2019.106339_bib0440 article-title: PGE2 reduces MMP expression and cell migration in neonatal ventricular fibroblasts publication-title: FASEB J. – volume: 268 start-page: 7759 issue: 11 year: 1993 ident: 10.1016/j.prostaglandins.2019.106339_bib0110 article-title: Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)53022-2 – volume: 130 start-page: 481 issue: 3 year: 2008 ident: 10.1016/j.prostaglandins.2019.106339_bib0300 article-title: Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front publication-title: Histochem. Cell Biol. doi: 10.1007/s00418-008-0464-1 – volume: 25 start-page: 92 issue: 2 year: 2015 ident: 10.1016/j.prostaglandins.2019.106339_bib0150 article-title: Understanding fibroblast heterogeneity in the skin publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2014.10.001 – volume: 289 start-page: 17151 issue: 24 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0415 article-title: Prostaglandin E2 inhibits alpha-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A publication-title: J. Biol. Chem. doi: 10.1074/jbc.M114.558130 – volume: 107 start-page: 11026 issue: 24 year: 2010 ident: 10.1016/j.prostaglandins.2019.106339_bib0295 article-title: Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0914295107 – volume: 113–115 start-page: 62 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0435 article-title: PGE2 reduces MMP-14 and increases plasminogen activator inhibitor-1 in cardiac fibroblasts publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2014.09.002 – volume: 49 start-page: 667 issue: 11 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0060 article-title: Cyclooxygenase 2: protein-protein interactions and posttranslational modifications publication-title: Physiol. Genomics doi: 10.1152/physiolgenomics.00086.2017 – volume: 214 start-page: 199 issue: 2 year: 2008 ident: 10.1016/j.prostaglandins.2019.106339_bib0180 article-title: Cellular and molecular mechanisms of fibrosis publication-title: J. Pathol. doi: 10.1002/path.2277 – volume: 14 start-page: 76 issue: 1-4 year: 2011 ident: 10.1016/j.prostaglandins.2019.106339_bib0250 article-title: Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos publication-title: J. Toxicol. Environ. Health Part B: Crit. Rev. doi: 10.1080/10937404.2011.556047 – volume: 23 start-page: 4317 issue: 12 year: 2009 ident: 10.1016/j.prostaglandins.2019.106339_bib0400 article-title: Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways publication-title: FASEB J. doi: 10.1096/fj.08-128801 – volume: 77 start-page: 700 issue: 3 year: 1986 ident: 10.1016/j.prostaglandins.2019.106339_bib0390 article-title: Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators publication-title: J. Clin. Invest. doi: 10.1172/JCI112364 – volume: 58 start-page: 107 issue: 1 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0445 article-title: An EP4 receptor agonist inhibits cardiac fibrosis through activation of PKA signaling in hypertrophied heart publication-title: Int. Heart J. doi: 10.1536/ihj.16-200 – volume: 275 start-page: 32775 issue: 42 year: 2000 ident: 10.1016/j.prostaglandins.2019.106339_bib0070 article-title: Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis publication-title: J. Biol. Chem. doi: 10.1074/jbc.M003504200 – volume: 122 start-page: 103 issue: 1 year: 1993 ident: 10.1016/j.prostaglandins.2019.106339_bib0165 article-title: Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts publication-title: J. Cell Biol. doi: 10.1083/jcb.122.1.103 – volume: 73 start-page: 3888 issue: 13 year: 2013 ident: 10.1016/j.prostaglandins.2019.106339_bib0345 article-title: Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-4150 – volume: 268 start-page: 20175 issue: 27 year: 1993 ident: 10.1016/j.prostaglandins.2019.106339_bib0105 article-title: Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(20)80710-8 – volume: 53 start-page: 630 issue: 4 year: 2012 ident: 10.1016/j.prostaglandins.2019.106339_bib0510 article-title: Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2 publication-title: J. Lipid Res. doi: 10.1194/jlr.M019695 – volume: 276 start-page: 161 year: 2009 ident: 10.1016/j.prostaglandins.2019.106339_bib0030 article-title: Fibroblasts-a diverse population at the center of it all publication-title: Int. Rev. Cell Mol. Biol. doi: 10.1016/S1937-6448(09)76004-6 – volume: 8 start-page: 3983 issue: 1 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0540 article-title: Global gene expression analysis in an in vitro fibroblast model of idiopathic pulmonary fibrosis reveals potential role for CXCL14/CXCR4 publication-title: Sci. Rep. doi: 10.1038/s41598-018-21889-7 – volume: 22 start-page: 628 issue: 5 year: 2000 ident: 10.1016/j.prostaglandins.2019.106339_bib0385 article-title: Different expression of TNF-alpha receptors and prostaglandin E(2)Production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/ajrcmb.22.5.3948 – volume: 10 start-page: 1403 issue: 11 year: 2012 ident: 10.1016/j.prostaglandins.2019.106339_bib0265 article-title: Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-12-0307 – volume: 64 start-page: 171 issue: 4 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0185 article-title: The role of myofibroblasts in wound healing publication-title: Curr. Res. Transl. Med. doi: 10.1016/j.retram.2016.09.003 – volume: 81 start-page: 80 issue: 2 year: 2002 ident: 10.1016/j.prostaglandins.2019.106339_bib0525 article-title: Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients publication-title: Ann. Hematol. doi: 10.1007/s00277-001-0410-y – volume: 379 start-page: 2281 issue: 23 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0135 article-title: Aspirin-exacerbated respiratory disease publication-title: N. Engl. J. Med. – volume: 10 start-page: 181 issue: 3 year: 2010 ident: 10.1016/j.prostaglandins.2019.106339_bib0490 article-title: Eicosanoids and cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2809 – volume: 4 start-page: 62 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0315 article-title: Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment publication-title: Front. Oncol. doi: 10.3389/fonc.2014.00062 – volume: 18 start-page: 62 issue: 1 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0360 article-title: Type 2 immunity in tissue repair and fibrosis publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2017.90 – volume: 35 start-page: 123 issue: 2 year: 2013 ident: 10.1016/j.prostaglandins.2019.106339_bib0025 article-title: Multifaceted roles of PGE(2) in inflammation and cancer publication-title: Semin. Immunopathol. doi: 10.1007/s00281-012-0342-8 – volume: 128 start-page: 45 issue: 1 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0205 article-title: Extracellular matrix as a driver of progressive fibrosis publication-title: J. Clin. Invest. doi: 10.1172/JCI93557 – volume: 120 start-page: 161 year: 2015 ident: 10.1016/j.prostaglandins.2019.106339_bib0140 article-title: Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2015.06.002 – volume: 128 start-page: 97 issue: 1 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0175 article-title: Resolution of organ fibrosis publication-title: J. Clin. Invest. doi: 10.1172/JCI93563 – volume: 14 start-page: 287 issue: 3 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0330 article-title: Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-15-0307 – volume: 531 start-page: 2 issue: 1 year: 2002 ident: 10.1016/j.prostaglandins.2019.106339_bib0055 article-title: Phospholipase A(2) regulation of arachidonic acid mobilization publication-title: FEBS Lett. doi: 10.1016/S0014-5793(02)03413-0 – volume: 27 start-page: 752 issue: 6 year: 2002 ident: 10.1016/j.prostaglandins.2019.106339_bib0395 article-title: Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/rcmb.4857 – volume: 112 start-page: 8070 issue: 26 year: 2015 ident: 10.1016/j.prostaglandins.2019.106339_bib0515 article-title: COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1424355112 – volume: 45 start-page: 1 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0255 article-title: Lung cancer in patients with idiopathic pulmonary fibrosis publication-title: Pulm. Pharmacol. Ther. doi: 10.1016/j.pupt.2017.03.016 – volume: 6 start-page: 392 issue: 5 year: 2006 ident: 10.1016/j.prostaglandins.2019.106339_bib0355 article-title: Fibroblasts in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1877 – volume: 340 start-page: 430 issue: 6 year: 1999 ident: 10.1016/j.prostaglandins.2019.106339_bib0240 article-title: Radial scars in benign breast-biopsy specimens and the risk of breast cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199902113400604 – volume: 19 start-page: 447 issue: 8 year: 2013 ident: 10.1016/j.prostaglandins.2019.106339_bib0280 article-title: ’Cancer associated fibroblasts’—more than meets the eye publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2013.05.004 – volume: 233 start-page: 98 issue: 1 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0160 article-title: TGFbeta signaling and the control of myofibroblast differentiation: implications for chronic inflammatory disorders publication-title: J. Cell. Physiol. doi: 10.1002/jcp.25879 – volume: 174 start-page: 5644 issue: 9 year: 2005 ident: 10.1016/j.prostaglandins.2019.106339_bib0555 article-title: Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2 publication-title: J. Immunol. doi: 10.4049/jimmunol.174.9.5644 – volume: 68–69 start-page: 483 year: 2002 ident: 10.1016/j.prostaglandins.2019.106339_bib0125 article-title: Prostaglandin catabolizing enzymes publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/S0090-6980(02)00050-3 – volume: 108 start-page: 319 issue: 1 year: 2013 ident: 10.1016/j.prostaglandins.2019.106339_bib0130 article-title: Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-012-0319-8 – volume: 340 start-page: 604 issue: 3 year: 2012 ident: 10.1016/j.prostaglandins.2019.106339_bib0470 article-title: Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.111.189845 – volume: 84 start-page: 147 issue: 5–6 year: 2011 ident: 10.1016/j.prostaglandins.2019.106339_bib0465 article-title: Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor publication-title: Prostaglandins Leukot. Essent. Fatty Acids doi: 10.1016/j.plefa.2011.01.003 – volume: 21 start-page: 652 issue: 5 year: 2015 ident: 10.1016/j.prostaglandins.2019.106339_bib0100 article-title: Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway publication-title: Hum. Reprod. Update doi: 10.1093/humupd/dmv026 – volume: 1791 start-page: 238 issue: 4 year: 2009 ident: 10.1016/j.prostaglandins.2019.106339_bib0115 article-title: EP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbalip.2009.01.021 – volume: 25 start-page: 735 issue: 6 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0340 article-title: Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2014.04.021 – volume: 324 start-page: 1457 issue: 5933 year: 2009 ident: 10.1016/j.prostaglandins.2019.106339_bib0285 article-title: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer publication-title: Science doi: 10.1126/science.1171362 – volume: 50 start-page: S423 issue: Suppl year: 2009 ident: 10.1016/j.prostaglandins.2019.106339_bib0040 article-title: Prostanoids in health and disease publication-title: J. Lipid Res. doi: 10.1194/jlr.R800094-JLR200 – volume: 14 start-page: 186 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0230 article-title: Imagine a world without cancer publication-title: BMC Cancer doi: 10.1186/1471-2407-14-186 – volume: 25 start-page: 604 issue: 8 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0450 article-title: Prostaglandin E2 inhibits collagen synthesis in dermal fibroblasts and prevents hypertrophic scar formation in vivo publication-title: Exp. Dermatol. doi: 10.1111/exd.13014 – volume: 4 start-page: eaar8320 issue: 9 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0045 article-title: PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo publication-title: Sci. Adv. doi: 10.1126/sciadv.aar8320 – volume: 25 start-page: 69 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0305 article-title: Regulation of the anti-tumour immune response by cancer-associated fibroblasts publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2013.12.005 – volume: 27 start-page: 399 issue: 8 year: 2006 ident: 10.1016/j.prostaglandins.2019.106339_bib0145 article-title: Is mPGES-1 a promising target for pain therapy? publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2006.06.001 – volume: 156 start-page: 835 issue: 5 year: 2009 ident: 10.1016/j.prostaglandins.2019.106339_bib0475 article-title: Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2008.00051.x – volume: 22 start-page: 57 issue: 1 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0095 article-title: Structural features of subtype-selective EP receptor modulators publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2016.08.003 – volume: 128 start-page: 26 issue: 1 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0155 article-title: Fibroblast heterogeneity: implications for human disease publication-title: J. Clin. Invest. doi: 10.1172/JCI93555 – volume: 128 start-page: 16 issue: 1 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0275 article-title: The fibrotic tumor stroma publication-title: J. Clin. Invest. doi: 10.1172/JCI93554 – volume: 25 start-page: 719 issue: 6 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0335 article-title: Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival publication-title: Cancer Cell doi: 10.1016/j.ccr.2014.04.005 – volume: 29 start-page: 537 issue: 5 year: 2003 ident: 10.1016/j.prostaglandins.2019.106339_bib0405 article-title: Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. Prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/rcmb.2002-0243OC – volume: 6 start-page: 1191 issue: 12 year: 2005 ident: 10.1016/j.prostaglandins.2019.106339_bib0010 article-title: Resolution of inflammation: the beginning programs the end publication-title: Nat. Immunol. doi: 10.1038/ni1276 – volume: 214 start-page: 579 issue: 3 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0320 article-title: Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer publication-title: J. Exp. Med. doi: 10.1084/jem.20162024 – volume: 148 start-page: 2142 issue: 7 year: 1992 ident: 10.1016/j.prostaglandins.2019.106339_bib0375 article-title: Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones publication-title: J. Immunol. doi: 10.4049/jimmunol.148.7.2142 – volume: 15 start-page: 511 issue: 8 year: 2015 ident: 10.1016/j.prostaglandins.2019.106339_bib0005 article-title: Eicosanoid storm in infection and inflammation publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3859 – volume: 66 start-page: 50 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0065 article-title: Prostaglandin synthases: molecular characterization and involvement in prostaglandin biosynthesis publication-title: Prog. Lipid Res. doi: 10.1016/j.plipres.2017.04.003 – volume: 28 start-page: 113 issue: 1–2 year: 2009 ident: 10.1016/j.prostaglandins.2019.106339_bib0325 article-title: Mechanics, malignancy, and metastasis: the force journey of a tumor cell publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-008-9173-4 – volume: 37 start-page: 317 issue: 2–3 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0485 article-title: mPGES-1 and ALOX5/-15 in tumor-associated macrophages publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-018-9731-3 – volume: 275 start-page: 32783 issue: 42 year: 2000 ident: 10.1016/j.prostaglandins.2019.106339_bib0085 article-title: Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M003505200 – volume: 65 start-page: 2 year: 2019 ident: 10.1016/j.prostaglandins.2019.106339_bib0200 article-title: Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications publication-title: Mol. Aspects Med. doi: 10.1016/j.mam.2018.06.003 – volume: 31 start-page: 986 issue: 5 year: 2011 ident: 10.1016/j.prostaglandins.2019.106339_bib0020 article-title: Prostaglandins and inflammation publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.110.207449 – volume: 10 start-page: 201 issue: 1 year: 2008 ident: 10.1016/j.prostaglandins.2019.106339_bib0235 article-title: Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence publication-title: Breast Cancer Res. doi: 10.1186/bcr1831 – volume: 32 start-page: 84 year: 2018 ident: 10.1016/j.prostaglandins.2019.106339_bib0520 article-title: Inhibition of microsomal prostaglandin e Synthase-1 in cancer-associated fibroblasts suppresses neuroblastoma tumor growth publication-title: EBioMedicine doi: 10.1016/j.ebiom.2018.05.008 – volume: 796 start-page: 7 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0120 article-title: Eicosanoid receptors: targets for the treatment of disrupted intestinal epithelial homeostasis publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2016.12.004 – volume: 16 start-page: 582 issue: 9 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0035 article-title: The biology and function of fibroblasts in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2016.73 – volume: 1831 start-page: 239 issue: 1 year: 2013 ident: 10.1016/j.prostaglandins.2019.106339_bib0195 article-title: Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbalip.2012.07.022 – volume: 316 start-page: 2713 issue: 17 year: 2010 ident: 10.1016/j.prostaglandins.2019.106339_bib0290 article-title: Activation of fibroblasts in cancer stroma publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2010.04.032 – volume: 135 start-page: 626 issue: 3 year: 2015 ident: 10.1016/j.prostaglandins.2019.106339_bib0365 article-title: The 3 major types of innate and adaptive cell-mediated effector immunity publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2014.11.001 – volume: 291 start-page: 884 issue: 4 year: 2002 ident: 10.1016/j.prostaglandins.2019.106339_bib0080 article-title: Identification and characterization of a novel type of membrane-associated prostaglandin E synthase publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.2002.6531 – volume: 164 start-page: 1015 issue: 5 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0270 article-title: TGF-beta tumor suppression through a lethal EMT publication-title: Cell doi: 10.1016/j.cell.2016.01.009 – volume: 159 start-page: 55 issue: 1–2 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0310 article-title: Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells publication-title: Immunol. Lett. doi: 10.1016/j.imlet.2014.03.001 – volume: 232 start-page: 202 issue: 1 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0455 article-title: Prostaglandin E2-dependent phosphorylation of RAS inhibition 1 (RIN1) at Ser 291 and 292 inhibits transforming growth factor-beta-induced RAS activation pathway in human synovial fibroblasts: role in cell migration publication-title: J. Cell. Physiol. doi: 10.1002/jcp.25412 – volume: 95 start-page: 1861 issue: 4 year: 1995 ident: 10.1016/j.prostaglandins.2019.106339_bib0380 article-title: Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2 publication-title: J. Clin. Invest. doi: 10.1172/JCI117866 – volume: 18 start-page: 11 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0210 article-title: MicroRNAs in fibrosis: opportunities and challenges publication-title: Arthritis Res. Ther. doi: 10.1186/s13075-016-0929-x – volume: 63 start-page: 1 year: 2017 ident: 10.1016/j.prostaglandins.2019.106339_bib0245 article-title: Stromal microenvironment in type VII collagen-deficient skin: the ground for squamous cell carcinoma development publication-title: Matrix Biol. doi: 10.1016/j.matbio.2017.01.002 – volume: 292 start-page: L405 issue: 2 year: 2007 ident: 10.1016/j.prostaglandins.2019.106339_bib0550 article-title: Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. doi: 10.1152/ajplung.00232.2006 – volume: 188 start-page: 21 issue: 1 year: 2012 ident: 10.1016/j.prostaglandins.2019.106339_bib0015 article-title: Regulation of immune responses by prostaglandin E2 publication-title: J. Immunol. doi: 10.4049/jimmunol.1101029 – volume: 16 start-page: 410 issue: 4 year: 2014 ident: 10.1016/j.prostaglandins.2019.106339_bib0530 article-title: Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression publication-title: Breast Cancer Res. doi: 10.1186/s13058-014-0410-1 – volume: 378 start-page: 617 issue: 6 year: 2008 ident: 10.1016/j.prostaglandins.2019.106339_bib0545 article-title: Role of Epac1 in mediating anti-proliferative effects of prostanoid EP(2) receptors and cAMP in human lung fibroblasts publication-title: Naunyn Schmiedebergs Arch. Pharmacol. doi: 10.1007/s00210-008-0334-3 – volume: 315 start-page: 1650 issue: 26 year: 1986 ident: 10.1016/j.prostaglandins.2019.106339_bib0260 article-title: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing publication-title: N. Engl. J. Med. doi: 10.1056/NEJM198612253152606 – volume: 76 start-page: 6205 issue: 21 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0505 article-title: Snail1-dependent activation of cancer-associated fibroblast controls epithelial tumor cell invasion and metastasis publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-16-0176 – volume: 365 start-page: 563 issue: 3 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0430 article-title: Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration publication-title: Cell Tissue Res. doi: 10.1007/s00441-016-2431-9 – volume: 133 start-page: 1578 issue: 7 year: 2013 ident: 10.1016/j.prostaglandins.2019.106339_bib0370 article-title: Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation publication-title: Int. J. Cancer doi: 10.1002/ijc.28181 – volume: 39 start-page: 482 issue: 4 year: 2008 ident: 10.1016/j.prostaglandins.2019.106339_bib0420 article-title: Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1 publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/rcmb.2008-0080OC – volume: 13 start-page: 2045 issue: 11 year: 2016 ident: 10.1016/j.prostaglandins.2019.106339_bib0225 article-title: Treatment of systemic sclerosis-related interstitial lung disease: a review of existing and emerging therapies publication-title: Ann. Am. Thorac. Soc. doi: 10.1513/AnnalsATS.201606-426FR – volume: 72 start-page: 1412 issue: 6 year: 1995 ident: 10.1016/j.prostaglandins.2019.106339_bib0500 article-title: Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators publication-title: Br. J. Cancer doi: 10.1038/bjc.1995.523 – volume: 3 start-page: 349 year: 2002 ident: 10.1016/j.prostaglandins.2019.106339_bib0170 article-title: Myofibroblasts and mechano-regulation of connective tissue remodelling publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm809 – volume: 175 start-page: 6924 issue: 10 year: 2005 ident: 10.1016/j.prostaglandins.2019.106339_bib0460 article-title: Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts publication-title: J. Immunol. doi: 10.4049/jimmunol.175.10.6924 – volume: 318 start-page: 154 issue: 2 year: 2012 ident: 10.1016/j.prostaglandins.2019.106339_bib0535 article-title: Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO publication-title: Cancer Lett. doi: 10.1016/j.canlet.2011.12.020 |
| SSID | ssj0020110 |
| Score | 2.36021 |
| SecondaryResourceType | review_article |
| Snippet | •Fibroblasts are the main cells of connective tissue and participate in wound repair upon activation.•Unchecked fibroblast activation leads to fibrosis and... Fibroblasts are the essential cellular architects of connective tissue and as such are crucial cells in contributing to organ homeostasis. While fulfilling... |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 106339 |
| SubjectTerms | Cancer COX Fibrosis mPGES-1 PGE2 |
| Title | PGE2 in fibrosis and cancer: Insights into fibroblast activation |
| URI | https://dx.doi.org/10.1016/j.prostaglandins.2019.106339 https://www.proquest.com/docview/2232052340 |
| Volume | 143 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 issn: 1098-8823 databaseCode: AIEXJ dateStart: 19980101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.sciencedirect.com omitProxy: false ssIdentifier: ssj0020110 providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pb9MwFLa6DiEuEzAQYzAZaeKCghInaWI4QDsVGIephyH1FjnO85TRpVXXdeO_5z07adahSQWJS1RFsZX0-_z8nt8vxg5VmANEUe5FOhBeFOfGk5DHnoKeNAb3e9krbLOJ5OQkHY_lqNO5bnJhlpOkqtKbGzn7r1DjPQSbUmf_Au7VpHgDfyPoeEXY8boR8KOvQ0GnGAYN4SmVG7GZawSu7Qh5XF2SPU5hWKh22ody1KAXtqrGssWpVlhHlBWibKMPCqYhoticrXeTclYWLvGEGva0MSDX6ic41_-wvGi5N7A--cGRO0EdwLxqEvqdY6g8q7OHbIilWjuOoAyotDmOcBKUCpSi2h6uidgovCUk0QoNXQWjP-S3O0o4p93j1sdRBJ583w5bL5t9ZztbBRk28Wvn2fpsGc2Wudm22LZIYpl22Xb_eDj-vrLVSS2yjvL6ax6ywzY08P63u0-7ubPPW-Xl9DHbqa0O3ndsecI6UD1lu_0Kobv4xd9yGwdsHSy77DMRiJcVbwjE8QW4I9AH3tCHE314Sx_e0ucZ-_FleHr0zav7bHg6DIX0BICfJsrXWiRFGkS5EYXIA6VjqbWBXEHuKx2CMkrhQjahkkonEQQ6kipGBfc561bTCl4wLopA--DnUuoern4UBCZOtDEAMYi4gD32sfl_Ml0XoadeKJNsE7T2WLwaPXPFWDYc96mBIqsVS6cwZsi7DWd40yCYofwlp5qqYHqFD6FJQq6VyH_5j2-3zx61C-kV6y7mV_CaPdDLRXk5P2BbyTg9qOn5G8GftJA |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PGE2+in+fibrosis+and+cancer%3A+Insights+into+fibroblast+activation&rft.jtitle=Prostaglandins+%26+other+lipid+mediators&rft.au=Elwakeel%2C+Eiman&rft.au=Br%C3%BCne%2C+Bernhard&rft.au=Weigert%2C+Andreas&rft.date=2019-08-01&rft.issn=1098-8823&rft.volume=143&rft.spage=106339&rft_id=info:doi/10.1016%2Fj.prostaglandins.2019.106339&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_prostaglandins_2019_106339 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-8823&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-8823&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-8823&client=summon |